FDA committee unanimously recommends 1st mRNA flu vaccine
Digest more
An interdisciplinary team of Rice University researchers has uncovered previously unknown relationships between bacteriophages—viruses that infect bacteria—and their bacterial hosts, offering a powerful new tool for next-generation microbiome engineering.
Irish Star on MSN
Scientists discover RNA damage, not DNA, causes sunburn inflammation in groundbreaking new study
The familiar sting and inflammation of sunburn may be caused by RNA damage rather than DNA damage, according to new research that could reshape our understanding of how skin responds to UV radiation
Genes are not passed on exclusively from parents to their offspring. Some are mobile and can also jump to other species, as researchers at the Max Planck Institute for Marine Microbiology in Bremen have now shown.
13don MSN
Continuous stirring made early life-like RNA systems more extinction-prone, experiment shows
Recent research showed that an artificially constructed self-replicating RNA system modeling primitive life at the origin of life evolved to become more prone to extinction under certain experimental conditions.
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
RNA therapeutics have emerged as one of the most promising new classes of medicines. Eight small interfering RNA (siRNA) drugs have already been approved worldwide for the treatment of genetic diseases,
Although there are striking differences between the cells that make up your eyes, kidneys, brain and toes, the DNA blueprint for these cells is essentially the same. Where do those differences come from? Scientists are realizing the defining qualities that ...
Proteins are how cells get work done. They carry out nearly every important cellular task, from ferrying messages to controlling which genes are turned on or off. And in order for proteins to perform their various roles,
The recent success of mRNA vaccines has heightened interest in RNA-based therapy, which significantly expands the scope of druggable targets. Currently, small interfering RNAs and antisense oligonucleotide drugs are being progressed in the clinic.
KRRO-110 miss drives overhaul; KRRO-121/111 show preclinical promise. Click here to read my most recent analysis of the stock.
